Sailash Patel has over 20 years of experience in the pharmaceutical industry including leadership roles in start-up and multinational companies. Most recently he was CEO for Meryx, a UNC spinout working in the immune-oncology space. Prior to that he was CFO and VP of Strategic Development for Furiex Pharmaceuticals where he led corporate development and finance functions before the company was acquired by Forest/Actavis for $1.3 billion. Prior to Furiex, he was General Manager of BioDuro, a wholly-owned subsidiary of PPD, where he was responsible for all functional aspects of a 700 employee China-based drug discovery unit, providing integrated discovery services to the pharmaceutical industry. While at PPD he also served as Vice President of Strategic Development where he was responsible for corporate strategic planning, mergers and acquisitions, and compound partnering business development. Sailash holds a master's degree in business administration from the Kenan-Flagler Business School at University of North Carolina, Chapel Hill and a bachelor's degree in pharmacy with honors from University of Nottingham in the U.K.